PARP1 and cancer: Notably, we also found that IFN-α promoted cancer cell survival as evidenced by higher colony number of IFN-α-treated cells in a clonogenic survival assay (Fig. 6c; quantitative results, lower panel) and reduced apoptotic cleavage of PARP-1 (Fig. 6d).